Swiss Life Asset Management’s Organon & Co OGN Stock Holding History
Bought
Maintained
Sold
Other funds holding OGN
PMG
AAM
Swiss Life Asset Management's OGN Position: Q2 2026 in Review
Swiss Life Asset Management reduced its Organon & Co (OGN) stake by 7.3% in Q2 2026, selling an estimated $31.2K and leaving 33,273 shares worth $451K. The position accounts for ﹤0.01% of the portfolio, ranked #1023.
Swiss Life Asset Management first reported a position in OGN in Q2 2021 and has held it in 11 quarters since. The position peaked at $2.8M in Q2 2021. 437 funds tracked by Wall St. Rank hold OGN as of Q2 2026.
- Swiss Life Asset Management held 33,273 shares of Organon & Co worth $451K as of Q2 2026.
- Swiss Life Asset Management sold 2,607 Organon & Co shares in Q2 2026, an estimated $31.2K.
- Organon & Co made up ﹤0.01% of Swiss Life Asset Management's portfolio in Q2 2026, its #1023 holding.
- Swiss Life Asset Management first reported a position in Organon & Co in Q2 2021 and has held it in 11 quarters since.
- Swiss Life Asset Management's Organon & Co position peaked at $2.8M in Q2 2021.
- 437 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.
Based on Swiss Life Asset Management's 13F filing for Q2 2026, filed 29 Jul 2026.